Development of cigarette smoke solution- and lipopolysaccharide-induced pulmonary emphysema in guinea pigs.
Mizutani
Nobuaki
N
mizutani@kobepharma-u.ac.jp
Fuchikami
Jun-Ichi
J
Takahashi
Maki
M
Nabe
Takeshi
T
Yoshino
Shin
S
Kohno
Shigekatsu
S
D000403:Airway Resistance; D000818:Animals; D001993:Bronchodilator Agents / Q000627:therapeutic use; D004195:Disease Models, Animal; D006168:Guinea Pigs; D008070:Lipopolysaccharides / Q000009:adverse effects; D008168:Lung / Q000473:pathology / Q000503:physiopathology; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D011656:Pulmonary Emphysema / Q000188:drug therapy / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D012129:Respiratory Function Tests; D012907:Smoking / Q000009:adverse effects; D012996:Solutions; D013806:Theophylline / Q000627:therapeutic use
D001993:Bronchodilator Agents; D008070:Lipopolysaccharides; D012996:Solutions; D013806:Theophylline